A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F20%3A43918899" target="_blank" >RIV/00216208:11120/20:43918899 - isvavai.cz</a>
Alternative codes found
RIV/00064173:_____/20:N0000042
Result on the web
<a href="https://doi.org/10.1210/clinem/dgz096" target="_blank" >https://doi.org/10.1210/clinem/dgz096</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1210/clinem/dgz096" target="_blank" >10.1210/clinem/dgz096</a>
Alternative languages
Result language
angličtina
Original language name
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Original language description
OBJECTIVE: The aim of the Acromegaly Consensus Group was to revise and update the consensus on diagnosis and treatment of acromegaly comorbidities last published in 2013. PARTICIPANTS: The Consensus Group, convened by 11 Steering Committee members, consisted of 45 experts in the medical and surgical management of acromegaly. The authors received no corporate funding or remuneration. EVIDENCE: This evidence-based Consensus was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence following critical discussion of the current literature on the diagnosis and treatment of acromegaly comorbidities. CONSENSUS PROCESS: Acromegaly Consensus Group participants conducted comprehensive literature searches for English-language papers on selected topics, reviewed brief presentations on each topic, and discussed current practice and recommendations in breakout groups. Consensus recommendations were developed based on all presentations and discussions. Members of the Scientific Committee graded the quality of the supporting evidence and the consensus recommendations using the GRADE system. CONCLUSIONS: Evidence-based approach consensus recommendations address important clinical issues regarding multidisciplinary management of acromegaly-related cardiovascular, endocrine, metabolic, and oncologic comorbidities, sleep apnea, and bone and joint disorders and their sequelae, as well as their effects on quality of life and mortality.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30202 - Endocrinology and metabolism (including diabetes, hormones)
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Clinical Endocrinology & Metabolism
ISSN
0021-972X
e-ISSN
—
Volume of the periodical
105
Issue of the periodical within the volume
4
Country of publishing house
US - UNITED STATES
Number of pages
10
Pages from-to
"e937"-"e946"
UT code for WoS article
000525950100051
EID of the result in the Scopus database
2-s2.0-85079399040